Gynuity envisions a world in which each individual has access to safe and effective reproductive and maternal health care—delivered where, when, and how needed.
Our mission is to develop scientific, clinical and programmatic evidence in reproductive and maternal health and to advocate for its use, assuring that everyone benefits from the fruits of science and technology. We do this on a global scale through research, strategic partnerships, and communications for impact.
Our Approach
Gynuity listens to women, providers and policymakers, and works with them to create services that are safe, high quality, and person-centered. Through conversations and active collaborations, we use research to fill evidence gaps for new models of care, influence change, and advocate for improvements in policy and practice.
Research
Our research demonstrates that simple, safe, and effective reproductive and maternal health technologies transform lives and improve outcomes for women and girls.
Policy and Practice
Through speaking, convening partners, and publishing our research, we create the synergies that trigger change in policy and practice.
Communications for Impact
Strategic communications increase the impact of our research and programmatic findings.
News
Latest Resources
Maximizing Impact: Our Plan of Action for 2025 to 2030
Feasibility and Acceptability of Outpatient Medical Induction at 13-18 Weeks’ Gestation in Public Sector Hospitals in Nepal: A Prospective Cohort Study
Preferences for Induction of Labor Methods in India: A Qualitative Study of Views and Experiences of Women, Clinicians, and Researchers
A sample protocol for providing medication abortion to selected patients without routine facility-based tests.
Read commentary and protocol
“Period pills” involve the use of uterine evacuation medications for treatment of delayed menses without prior pregnancy confirmation.
Find out more
A systematic review and meta-analysis (2023) of available data on the effectiveness and safety of misoprostol-only for medication abortion in the first 12 weeks of gestation.
Read key findings
TeleAborto is our research project in Mexico on the provision of medication abortion services using telemedicine. TeleAborto es nuestro proyecto de investigación en México sobre la prestación de servicios de aborto con medicamentos utilizando la telemedicina.
Visit the website (in Spanish only). Visite el sitio web (solo en español)
Researchers and grassroots activists partnered to explore the emerging landscape of self-managed abortion with support over the internet.
Read our analysis
A seven-part podcast series charting how mifepristone came to the U.S. in the 1990s. Ep. 6 of ‘The Pill Plot’ includes clips from an interview with the president of Gynuity Health Projects.
Listen now or save for later
Gynuity's image bank offers illustrations that can help articulate concepts across audiences. Available for download.
View image bank